CLINICAL_TRIALS
trial_result
· 2022-12-06
Clinical Trial Update: Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19 [Phase 3]
Summary
Phase 3 trial of Tanreqing Capsules for novel coronavirus pneumonia (COVID-19) completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Novel Coronavirus Pneumonia | Phase 3 | Status: COMPLETED